Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
   PubMed Web of Science ®Google Scholar
• Alfred Witjes J, Lebret T, Compérat EM, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71:462–475.
   PubMed Web of Science ®Google Scholar
• Hautmann RE, de Petriconi RC, Pfeiffer C, et al. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol. 2012;61:1039–1047.
   PubMed Web of Science ®Google Scholar
• Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol. 2010;184:990–994.
   PubMed Web of Science ®Google Scholar
• Longo N, Imbimbo C, Fusco F, et al. Complications and quality of life in elderly patients with high comorbidities who underwent cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy. BJU Int. 2016;18:521–526.
   Web of Science ®Google Scholar
• Stein JP, Skinner DG. Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J Urol. 2006;24:296–304.
   PubMed Web of Science ®Google Scholar
• Cancer of the urinary bladder-SEER stat fact sheets; 2016; [cited 2016 Dec 20]. Available from: http://seer.cancer.gov/statfacts/html/urinb.html
   Google Scholar
• Mak RH, Hunt D, Shipley WU, et al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. JCO. 2014;32:3801–3809.
   PubMed Web of Science ®Google Scholar
• Efstathiou JA, Spiegel DY, Shipley WU, et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol. 2012;61:705–711.
   PubMed Web of Science ®Google Scholar
• Ploussard G, Daneshmand S, Efstathiou JA, et al. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur Urol. 2014;66:120–137.
   PubMed Web of Science ®Google Scholar
• Galsky MD, Pal SK, Chowdhury S, et al. Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer. Cancer. 2015;121:2586–2593.
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–675.
   PubMed Web of Science ®Google Scholar
• Nielsen ME, Shariat SF, Karakiewicz PI, et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol. 2007;51:699–706, 708.
   PubMed Web of Science ®Google Scholar
• Patel MI, Bang A, Gillatt D, et al. Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study. BJU Int. 2015;116 Suppl 3:18–25.
   PubMed Web of Science ®Google Scholar
• Kotwal S, Choudhury A, Johnston C, et al. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom Specialist Treatment Center. Int J Radiat Oncol Biol Phys. 2008;70:456–463.
   PubMed Web of Science ®Google Scholar
• Munro NP, Sundaram SK, Weston PMT, et al. A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK. Int J Radiat Oncol Biol Phys. 2010;77:119–124.
   PubMed Web of Science ®Google Scholar
• Booth CM, Siemens DR, Li G, et al. Curative therapy for bladder cancer in routine clinical practice: a population-based outcomes study. Clin Oncol. 2014;26:506–514.
   PubMed Web of Science ®Google Scholar
• Chamie K, Hu B, Devere White RW, et al. Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int. 2008;102:284–290.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
   PubMedGoogle Scholar
• Miller DC, Taub DA, Dunn RL, et al. The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol. 2003;169:105–109.
   PubMed Web of Science ®Google Scholar
• Koppie TM, Serio AM, Vickers AJ, et al. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer. 2008;112:2384–2392.
   PubMed Web of Science ®Google Scholar
• Schiffmann J, Gandaglia G, Larcher A, et al. Contemporary 90-day mortality rates after radical cystectomy in the elderly. Eur J Surg Oncol. 2014;40:1738–1745.
   PubMed Web of Science ®Google Scholar